OR2A13P

Across TCGA pan-cancer cohorts, OR2A13P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated OR2A13P data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher OR2A13P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated OR2A13P expression acts as an unfavorable survival marker, although some lineages such as SKCM and MESO show a favorable association.

SKCM, CESC, and LGG are the cancer types where OR2A13P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	III,IV	0.465	0.141	<.001	47	view →
CESC	DFS	Median	All	0.772	0.867	.007	42	view →
LGG	OS	Tertile	All	0.335	0.552	.002	36	view →
MESO	DFS	Tertile	IV	0.858	0.430	.017	19	view →
LUAD	DFS	Quartile	III,IV	0.773	0.317	<.001	18	view →
THYM	DFS	Median	III,IV	1.000	0.501	.018	17	view →
SARC	OS	Tertile	All	0.890	0.813	.015	13	view →
LAML	DFS	Tertile	All	0.468	0.619	.017	12	view →
BLCA	DFS	Quartile	All	0.214	0.458	.031	10	view →
GBM	OS	Tertile	All	0.281	0.428	.043	9	view →
ESCA	OS	Quartile	III,IV	0.748	0.443	.016	9	view →
COAD	DFS	Quartile	II,III,IV	0.658	0.806	.026	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

OR2A13P–SKCM (DFS)

Open the SKCM breakdown →